{"adverse_reactions":[""],"clinical_pharmacology":[""],"contraindications":[""],"description":[""],"dosage_and_administration":[""],"dosage_forms_and_strengths":[""],"drug_interactions":[""],"effective_time":"20250702","how_supplied":[""],"id":"38eff751-96c6-c48a-e063-6294a90a0e48","indications_and_usage":[""],"nonclinical_toxicology":[""],"openfda":{"application_number":["NDA016267"],"brand_name":["Desferal"],"generic_name":["DEFEROXAMINE MESYLATE"],"is_original_packager":[true],"manufacturer_name":["MITEM PHARMA"],"package_ndc":["87081-467-91"],"product_ndc":["87081-467"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS","SUBCUTANEOUS"],"rxcui":["1731350","1731352"],"spl_id":["38eff751-96c6-c48a-e063-6294a90a0e48"],"spl_set_id":["38eff751-96c5-c48a-e063-6294a90a0e48"],"substance_name":["DEFEROXAMINE MESYLATE"],"unii":["V9TKO7EO6K"]},"overdosage":[""],"package_label_principal_display_panel":["Desferal LBL Desferal PI USA"],"set_id":"38eff751-96c5-c48a-e063-6294a90a0e48","spl_product_data_elements":["Desferal deferoxamine mesylate DEFEROXAMINE MESYLATE DEFEROXAMINE"],"spl_unclassified_section":[""],"use_in_specific_populations":[""],"version":"1","warnings_and_cautions":[""]}